BACKGROUND: Clostridium difficile toxin A is responsible for colonic damage observed in infected patients. Drugs able to restore Clostridium difficile toxin A-induced toxicity have the potential to improve the recovery of infected patients. Cannabidiol is a non-psychotropic component of Cannabis sativa, which has been demonstrated to protect enterocytes against chemical and/or inflammatory damage and to restore intestinal mucosa integrity. OBJECTIVE: The purpose of this study was to evaluate (a) the anti-apoptotic effect and (b) the mechanisms by which cannabidiol protects mucosal integrity in Caco-2 cells exposed to Clostridium difficile toxin A. METHODS: Caco-2 cells were exposed to Clostridium difficile toxin A (30 ng/ml), with or without cannabidiol (10-7-10-9 M), in the presence of the specific antagonist AM251 (10-7 M). Cytotoxicity assay, transepithelial electrical resistence measurements, immunofluorescence analysis and immunoblot analysis were performed in the different experimental conditions. RESULTS: Clostridium difficile toxin A significantly decreased Caco-2 cells' viability and reduced transepithelial electrical resistence values and RhoA guanosine triphosphate (GTP), bax, zonula occludens-1 and occludin protein expression, respectively. All these effects were significantly and concentration-dependently inhibited by cannabidiol, whose effects were completely abolished in the presence of the cannabinoid receptor type 1 (CB1) antagonist, AM251. CONCLUSIONS: Cannabidiol improved Clostridium difficile toxin A-induced damage in Caco-2 cells, by inhibiting the apoptotic process and restoring the intestinal barrier integrity, through the involvement of the CB1 receptor.
BACKGROUND: Clostridium difficile toxin A is responsible for colonic damage observed in infected patients. Drugs able to restore Clostridium difficile toxin A-induced toxicity have the potential to improve the recovery of infected patients. Cannabidiol is a non-psychotropic component of Cannabis sativa, which has been demonstrated to protect enterocytes against chemical and/or inflammatory damage and to restore intestinal mucosa integrity. OBJECTIVE: The purpose of this study was to evaluate (a) the anti-apoptotic effect and (b) the mechanisms by which cannabidiol protects mucosal integrity in Caco-2 cells exposed to Clostridium difficile toxin A. METHODS: Caco-2 cells were exposed to Clostridium difficile toxin A (30 ng/ml), with or without cannabidiol (10-7-10-9 M), in the presence of the specific antagonist AM251 (10-7 M). Cytotoxicity assay, transepithelial electrical resistence measurements, immunofluorescence analysis and immunoblot analysis were performed in the different experimental conditions. RESULTS: Clostridium difficile toxin A significantly decreased Caco-2 cells' viability and reduced transepithelial electrical resistence values and RhoA guanosine triphosphate (GTP), bax, zonula occludens-1 and occludin protein expression, respectively. All these effects were significantly and concentration-dependently inhibited by cannabidiol, whose effects were completely abolished in the presence of the cannabinoid receptor type 1 (CB1) antagonist, AM251. CONCLUSIONS: Cannabidiol improved Clostridium difficile toxin A-induced damage in Caco-2 cells, by inhibiting the apoptotic process and restoring the intestinal barrier integrity, through the involvement of the CB1 receptor.
Authors: Gerly A C Brito; Jun Fujji; Benedito A Carneiro-Filho; Aldo A M Lima; Tom Obrig; Richard L Guerrant Journal: J Infect Dis Date: 2002-10-29 Impact factor: 5.226
Authors: Mateus Machado Bergamaschi; Regina Helena Costa Queiroz; Antonio Waldo Zuardi; José Alexandre S Crippa Journal: Curr Drug Saf Date: 2011-09-01
Authors: Daniele De Filippis; Giuseppe Esposito; Carla Cirillo; Mariateresa Cipriano; Benedicte Y De Winter; Caterina Scuderi; Giovanni Sarnelli; Rosario Cuomo; Luca Steardo; Joris G De Man; Teresa Iuvone Journal: PLoS One Date: 2011-12-06 Impact factor: 3.240
Authors: Giuseppe Esposito; Chiara Corpetti; Marcella Pesce; Luisa Seguella; Giuseppe Annunziata; Alessandro Del Re; Martina Vincenzi; Roberta Lattanzi; Jie Lu; Walter Sanseverino; Giovanni Sarnelli Journal: Front Pharmacol Date: 2021-04-27 Impact factor: 5.810
Authors: Chiara Corpetti; Alessandro Del Re; Luisa Seguella; Irene Palenca; Sara Rurgo; Barbara De Conno; Marcella Pesce; Giovanni Sarnelli; Giuseppe Esposito Journal: Phytother Res Date: 2021-10-12 Impact factor: 6.388
Authors: Cristian Scheau; Constantin Caruntu; Ioana Anca Badarau; Andreea-Elena Scheau; Anca Oana Docea; Daniela Calina; Ana Caruntu Journal: J Pers Med Date: 2021-05-31